Search
Search
About
Log in
Join
Experiences with
Colon cancer
Posts
Communities
31,743 public posts
Filter results
WORRIED ABOUT REOCCURRENCE???
Worried....
Stopped IMRT 1 year ago and stopped adt (4 mos) 9 months ago...
9/23/23 Blood Test PSA .1 --- PSA FREE undetectable and Testosterone was 98
3/4/24 Blood Test PSA .2 ----Psa Free Undetectable and Testosterone not in yet.
I am concerned about the increase
Worried....
Stopped IMRT 1 year ago and stopped adt (4 mos) 9 months ago...
9/23/23 Blood Test PSA .1 --- PSA FREE undetectable and Testosterone was 98
3/4/24 Blood Test PSA .2 ----Psa Free Undetectable and Testosterone not in yet.
I am concerned about the increase
JWS13
in
Advanced Prostate Cancer
7 months ago
State 3 Breast Cancer
I discovered a lump in my breast early in April. Was sent for an ultrasound which was very suspicious. Biopsy revealed cancer. Oncololgist confirmed stage 3 metastic breast cancer. She put me on Anastrozole and when final tests came in started me on Ibrance 100. After two weeks my wbc was very low
I discovered a lump in my breast early in April. Was sent for an ultrasound which was very suspicious. Biopsy revealed cancer. Oncololgist confirmed stage 3 metastic breast cancer. She put me on Anastrozole and when final tests came in started me on Ibrance 100. After two weeks my wbc was very low
catfreddie
in
SHARE Metastatic Breast Cancer
3 months ago
Pet Scan = "disease not detected"
Ok folks, has anyone come across something like this?...early 2018, PSA in the 50's, biopsy came back negative, a few months later PSA in the 60's, again, another biopsy and a negative finding, 3rd time in the 80's with yet another negative biopsy, then nuclear imaging and bam...stage 4 metastatic, this
Ok folks, has anyone come across something like this?...early 2018, PSA in the 50's, biopsy came back negative, a few months later PSA in the 60's, again, another biopsy and a negative finding, 3rd time in the 80's with yet another negative biopsy, then nuclear imaging and bam...stage 4 metastatic, this
GreyDragon55
in
Advanced Prostate Cancer
7 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Moving on to Provenge/Sipuleucel-t
We met with my husband's onc yesterday to discuss the next move since the 3 years of Abiraraterone/prednisone has run its course. His psa numbers are now around 2.0 (up from a low of .04) and psma scan indicates that bone met volume is quite low. A recent lab biopsy didn't reveal much... The good doc
We met with my husband's onc yesterday to discuss the next move since the 3 years of Abiraraterone/prednisone has run its course. His psa numbers are now around 2.0 (up from a low of .04) and psma scan indicates that bone met volume is quite low. A recent lab biopsy didn't reveal much... The good doc
Lavender22
in
Advanced Prostate Cancer
5 months ago
SeHCAT scan - eeek!
Got my letter through to book the SeHCAT scan. I'm just freaked out by having to go to the same clinic that caused me so much distress during colonoscopies/endoscopies. I know this won't hurt and logically I don't need to worry but I can't help it.🙄
Got my letter through to book the SeHCAT scan. I'm just freaked out by having to go to the same clinic that caused me so much distress during colonoscopies/endoscopies. I know this won't hurt and logically I don't need to worry but I can't help it.🙄
Merry_Widow
in
IBS Network
7 months ago
Should the dose of Dutasteride be increased?
The plot above shows the residual (nadir) level of DHT in men as a function of the daily Dutasteride dose (mg/day). The DHT nadir numbers shown in this plot are: 23.8 pg/mL for 0.5 mg daily dose; 10.2 pg/mL for 2.5 mg daily dose; and 7.3 pg/mL for 5 mg daily dose. Ref: Clark (2004) [see Table
The plot above shows the residual (nadir) level of DHT in men as a function of the daily Dutasteride dose (mg/day). The DHT nadir numbers shown in this plot are: 23.8 pg/mL for 0.5 mg daily dose; 10.2 pg/mL for 2.5 mg daily dose; and 7.3 pg/mL for 5 mg daily dose. Ref: Clark (2004) [see Table
janebob99
in
Advanced Prostate Cancer
7 months ago
Should the dose of Dutasteride be increased?
The plot above shows the residual (nadir) level of DHT in men as a function of the daily Dutasteride dose (mg/day). The DHT nadir numbers shown in this plot are: 23.8 pg/mL for 0.5 mg daily dose; 10.2 pg/mL for 2.5 mg daily dose; and 7.3 pg/mL for 5 mg daily dose. Ref: Clark (2004) [see Table
The plot above shows the residual (nadir) level of DHT in men as a function of the daily Dutasteride dose (mg/day). The DHT nadir numbers shown in this plot are: 23.8 pg/mL for 0.5 mg daily dose; 10.2 pg/mL for 2.5 mg daily dose; and 7.3 pg/mL for 5 mg daily dose. Ref: Clark (2004) [see Table
janebob99
in
Prostate Cancer Network
7 months ago
Free Genetic Testing Promise Trial
When I was diagnosed with this cancer and looked into this forum for guidance the topic of genetic testing and its potential applications sounded like something I should investigate since I had no info on my biological father’s medical history and my mom died of cervical cancer. My local urologist wanted
When I was diagnosed with this cancer and looked into this forum for guidance the topic of genetic testing and its potential applications sounded like something I should investigate since I had no info on my biological father’s medical history and my mom died of cervical cancer. My local urologist wanted
Mgtd
in
Advanced Prostate Cancer
3 months ago
Tough decision
I've been on AS for 5 years with Moffit had 3 biopsy's all gleason 6 except a second opinion on my first one 2 cores where changed to a 7. PSA has bounced around but highest was 6.43 this April last week 5.13. Because of my recent MRI shows growth on the lesion and possible extracasular extension. So
I've been on AS for 5 years with Moffit had 3 biopsy's all gleason 6 except a second opinion on my first one 2 cores where changed to a 7. PSA has bounced around but highest was 6.43 this April last week 5.13. Because of my recent MRI shows growth on the lesion and possible extracasular extension. So
twoodogs
in
Prostate Cancer Network
3 months ago
Repost results
Im taking teva levothyroxine 100mcgThybon t3, 15mcg, split 3 x 5mcg dose Magnesium glycinate 650mg Vit D3,k2 mk-7, 5000iu Any advice very much appreciated 🌸🌸🌸🌸🌸🌸🌸
Im taking teva levothyroxine 100mcgThybon t3, 15mcg, split 3 x 5mcg dose Magnesium glycinate 650mg Vit D3,k2 mk-7, 5000iu Any advice very much appreciated 🌸🌸🌸🌸🌸🌸🌸
Geegee777
in
Thyroid UK
7 months ago
Has anyone had breast cancer Mets in para aortic lymph nodes?
after a solitary bone met which has been managed for a few years, I now have breast cancer Mets in my para aortic lymph nodes. I’m on Fulvestrant.
after a solitary bone met which has been managed for a few years, I now have breast cancer Mets in my para aortic lymph nodes. I’m on Fulvestrant.
Thredbo2
in
SHARE Metastatic Breast Cancer
3 months ago
Has anyone had breast cancer Mets in para aortic lymph nodes?
after a solitary bone met which has been managed for a few years, I now have breast cancer Mets in my para aortic lymph nodes. I’m on Fulvestrant.
after a solitary bone met which has been managed for a few years, I now have breast cancer Mets in my para aortic lymph nodes. I’m on Fulvestrant.
Thredbo2
in
SHARE Metastatic Breast Cancer
3 months ago
cisplatin
Hi, I was on Carboplatin, Avastin and Zem, but I got an allergic reaction from Carboplatin. My oncologist told me he will replace Carboplatin with Cisplarin for my 5 session. I am wondering if someone has been on Cisplatin and what’s yours experience with Cisplatin?
Hi, I was on Carboplatin, Avastin and Zem, but I got an allergic reaction from Carboplatin. My oncologist told me he will replace Carboplatin with Cisplarin for my 5 session. I am wondering if someone has been on Cisplatin and what’s yours experience with Cisplatin?
Green999
in
My Ovacome
3 months ago
LVV Update
Hello, just getting back with the latest on what appears to be a huge LVV flare. Had the PET Scan on Thursday and doc called yesterday. I have the scan but can’t really read it other than to see that there is no “hyper metabolic intra cranial lesion” or “FDG avid cervical or supraclavicular lymphadenopathy
Hello, just getting back with the latest on what appears to be a huge LVV flare. Had the PET Scan on Thursday and doc called yesterday. I have the scan but can’t really read it other than to see that there is no “hyper metabolic intra cranial lesion” or “FDG avid cervical or supraclavicular lymphadenopathy
LemonZest11
in
PMRGCAuk
3 months ago
Letrozole weight gain
Hi, I am posting this on behalf of my mum who suffered from breast cancer 2022-2023 she went through surgery, chemo and radiation and she is now clear of breast cancer. however she has to take Letrozole for 5 years and she is really struggling with the side effects she has put on a lot of weight since
Hi, I am posting this on behalf of my mum who suffered from breast cancer 2022-2023 she went through surgery, chemo and radiation and she is now clear of breast cancer. however she has to take Letrozole for 5 years and she is really struggling with the side effects she has put on a lot of weight since
MyStar86
in
My Breast Cancer Community
7 months ago
A recent MRI of the Abdomen
6/28/24- I am about to start calquence. I would appreciate your words of encouragement and advice. Follow-up mLeft upper pole 1.8 cm hypoenhancing solid renal lesion concerning for renal cell carcinoma, papillary subtype. Less likely differential of lymphomatous lesion. Innumerable additional
6/28/24- I am about to start calquence. I would appreciate your words of encouragement and advice. Follow-up mLeft upper pole 1.8 cm hypoenhancing solid renal lesion concerning for renal cell carcinoma, papillary subtype. Less likely differential of lymphomatous lesion. Innumerable additional
bagelstreet225
in
CLL Support
3 months ago
PET Scan Results 030424
New PSMA avid sclerotic lesions in the left inferior pubic ramus, and bilateral symphysis pubis. Additional new small foci in the left acetabulum and supra-acetabular region. Index focus in the left symphysis pubis with a maximum SUV 20.4. RO will radiate but suggests change from Zytiga to Xtandi.
New PSMA avid sclerotic lesions in the left inferior pubic ramus, and bilateral symphysis pubis. Additional new small foci in the left acetabulum and supra-acetabular region. Index focus in the left symphysis pubis with a maximum SUV 20.4. RO will radiate but suggests change from Zytiga to Xtandi.
alperk
in
Advanced Prostate Cancer
7 months ago
Can Fenbendazole be taken along with Orgovyx?
My husband has just been diagnosed with advanced prostate cancer. The doctor plans to do a scan to see if it has spread and then put him on Orgovyx. I am concerned about side effects (he is 86) and was hoping fenbendazole could be used at the same time to help things along. Does anyone have experience
My husband has just been diagnosed with advanced prostate cancer. The doctor plans to do a scan to see if it has spread and then put him on Orgovyx. I am concerned about side effects (he is 86) and was hoping fenbendazole could be used at the same time to help things along. Does anyone have experience
chochip4
in
Prostate Cancer Network
7 months ago
Low testosterone is associated with extremely poor survival metrics, post-ADT.
These companion plots compare: (A) median survival times, (B) PSA doubling times, and (C) Time to PSA Failure for two different levels of testosterone: Low and Normal. The low testosterone has a median value of 162 ng/dL [120-236] and the average normal T = 680 ng/dL. The cohort is 58 men with unfavorable
These companion plots compare: (A) median survival times, (B) PSA doubling times, and (C) Time to PSA Failure for two different levels of testosterone: Low and Normal. The low testosterone has a median value of 162 ng/dL [120-236] and the average normal T = 680 ng/dL. The cohort is 58 men with unfavorable
janebob99
in
Prostate Cancer Network
7 months ago
CAR T-Cell Therapy Demonstrates Promising Results for mCRPC
A total of 14 patients were treated between August 2019 and July 2022. The median patient age was 62 in dose level 1 (DL1), 70 for dose level 2 (DL2), and 69 for dose level 3 (DL3). The baseline prostate-specific antigen (PSA) ranged from 16.5 ng/mL to 235.3 ng/mL. Primary end points were safety and
A total of 14 patients were treated between August 2019 and July 2022. The median patient age was 62 in dose level 1 (DL1), 70 for dose level 2 (DL2), and 69 for dose level 3 (DL3). The baseline prostate-specific antigen (PSA) ranged from 16.5 ng/mL to 235.3 ng/mL. Primary end points were safety and
God_Loves_Me
in
Advanced Prostate Cancer
3 months ago
1
...
67
68
69
...
100
Next page
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
12557 results
My Ovacome
3585 results
SHARE Metastatic Breast Cancer
2225 results
View top 10 communities
Sort by
Most Relevant
Newest